LDS/Medical Tests/Pheniramine, Urine

Pheniramine, Urine

Pheniramine is a first generation H1 receptor antagonist antihistamine. Antihistamines are compounds that act as antagonists to the body’s release of histamine from mast cells. H1 and H2 antagonists, more commonly called antihistamines, have been produced to combat the effects of histamine.

Pheniramine has multiple routes of administration, including ophthalmic, nasal, and oral. Pheniramine prevents histamine release from mast cells and therefore inhibits its effects on conjunctival epithelial cells. The duration of the physiological action is usually between 4-6 hours. The metabolism of Pheniramine is not well described.

Although antihistamines have a wide use in our society today and can be obtained without a prescription, pheniramine is not considered in the clinical laboratory as a drug of abuse. Therefore, there are no commercial immunoassay kits available for detection. A therapeutic concentration range of pheniramine has been reported to be 0.01 to 0.19 µg/mL in blood.

  • Therapeutic monitoring
  • Postoperative analgesia
  • Toxicity assessment
  • Patient Compliance
Since these drugs are not considered as “drugs of abuse” any antihistamine detected should be viewed as “within the therapeutic range” or “outside the therapeutic range” or as “toxic.”

Therapeutic Level: 0.01 – 0.19 µg/mL
Toxic level: >5 mg/mL

Note: therapeutic ranges and toxic thresholds are best evaluated from blood samples. Quantitative results obtained with blood samples collected at specific times after drug administrations are preferred for pharmacokinetic analyses.    

Cut-Off Ranges
Cut-off values can vary based on the particular method of analysis that is used for detection by a quantitative method, such as LC/MS or GC/MS. The testing laboratory cut-off range is listed on the patient report. Consult your physician for further information or click on one of the references that are listed below.

Liquid Chromatography/Mass Spectroscopy (LC/MS) or Gas Chromatography/Mass Spectroscopy (GC/MS). The preferred method of detection is LC/MS. The main method of quantitation detection is via LC/MS or LC/MS/MS (liquid chromatography coupled with mass spectroscopy).

Fresh urine specimen collected in either a clean glass or plastic container. An acceptable urine specimen submitted for testing should be in the pH range of 3-11. Adulteration of the urine specimen can result in erroneous results.

Stability

  • Ambient: 3-5 days
  • Refrigeration: 7-14 days
  • Frozen: 30 days

 

Both LC/MS or GC/MS are considered the “gold standard” in testing for this class of drugs. Therefore, no additional confirmation of testing is required.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Baselt RC (ed). Analytical procedures for therapeutic drug monitoring and emergency toxicology, 2nd ed. Littleton, MA: PSG Publishing Co.; 1987.
  • Baselt RC (ed). Disposition of toxic drugs and chemicals in man, 9th ed. Foster City, CA: Biomedical Publications; 2011.
  • Baselt RC (ed). Disposition of toxic drugs and chemicals in man, 6th ed. Forster City, CA: Biomedical Publications; 2002.
  • Gupta RN. Review: drug level monitoring: sedative hypnotics. J Chromatography. 1985;340:139-72.
  • Levine B (ed). Principles of Forensic Toxicology, 4th ed. Washington DC: AACC Press. Chapter 25, Antihistamines pp. 435-440; 2013.
  • Brunton LL, Chabner B, Knollman B, eds. Goodman and Gilmans’ the pharmacological basis of therapeutics, 12th ed. New York: McGraw-Hill; 2010.
  • Cooper FJ, Logan BK. Drugs and human performance fact sheets. Washington, DC: National Highway Traffic Safety Administration, U.S. Department of Transportation. DOT HS 809 725; 2004.
  • Katzung BG, Masters S, Trevor AK (eds). Basic and clinical pharmacology, 12th ed. New York: McGraw-Hill; 2011.
  • Queree EA, et al. Therapeutic and Toxic Levels of Pheniramine in Biological Specimens, J Anal Toxicology. November-December 1979;3(6):253-255.
  • Stout PR, Farrell LJ. Opioids – Effects on human performance and behavior. Forensic Sci Rev. 2002;15:29-59.
  • Wu A (ed). Tietz, clinical guide to laboratory test, 4th ed. Philadelphia: WB Saunders; 2006.